Perseus Proteomics Balance Sheet Health
Financial Health criteria checks 6/6
Perseus Proteomics has a total shareholder equity of ¥1.6B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥1.8B and ¥241.0M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | n/a |
Cash | JP¥1.66b |
Equity | JP¥1.56b |
Total liabilities | JP¥241.00m |
Total assets | JP¥1.80b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4882's short term assets (¥1.8B) exceed its short term liabilities (¥99.0M).
Long Term Liabilities: 4882's short term assets (¥1.8B) exceed its long term liabilities (¥142.0M).
Debt to Equity History and Analysis
Debt Level: 4882 is debt free.
Reducing Debt: 4882 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4882 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 4882 has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 30% each year.